Navigation Links
DIA 2013 49th Annual Meeting to Address Hot Topics Surrounding Patient Therapies
Date:4/3/2013

Horsham, PA (PRWEB) April 03, 2013

The DIA 2013 49th Annual Meeting, to be held June 23–27 at the Boston Convention & Exhibition Center, will feature 22 tracks and more than 250 educational offerings, including sessions addressing urgent issues surrounding patient advocacy, big data and Alzheimer’s. These sessions, along with a large number of panels, forums and networking opportunities, aim to foster collaboration and drive conversation between patients and key industry and regulation professionals to advance the development and regulation of safe and effective medical products.

Sessions include:

Big Data: Impact on Innovation, June 25, 10:15 a.m. - Susan Dentzer, editor-in-chief of the leading peer-reviewed medical journal Health Affairs, will chair this discussion about how data are being used to support safety and efficiency, about how data affect the payer landscape, and to share best practices. Dentzer will be joined by keynote speaker Michael Rosenblatt, chief medical officer of Merck & Co., along with an esteemed panel of experts representing the pharmaceutical industry, regulatory affairs, clinical research and patient perspectives.

Advancing Alzheimer’s Innovation, June 26 - A variety of sessions will focus on advancing care in Alzheimer’s disease, bringing together representatives from the patient advocacy and industry communities.


Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
3. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
4. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
5. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
6. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
7. 15-Minute Data From Phase 3 Study of Avanafil Featured as a Late Breaking Abstract at SMSNA Annual Meeting
8. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
9. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
10. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
11. A New Mechanism for Tau Protein Pathology in Alzheimers Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014  Xencor, Inc. ... company developing engineered monoclonal antibodies for the treatment ... cancer, today announced the appointment of Debra ... and the appointment of Lloyd Rowland , ... counsel. "Debra,s expertise in biologics ...
(Date:9/2/2014)... , Sept. 2, 2014  Synthetic Biologics, Inc. ... biologic and drug candidates targeting specific pathogens that ... results from its final preclinical toxicology study of ... guidance, this bridging study was required to move ... to prevent the devastating effects of Clostridium ...
(Date:9/2/2014)... NC (PRWEB) September 02, 2014 ... of its 11th clinical research site: PMG Research of ... ownership and operation of the clinical research department at ... expanding PMG’s presence in eastern North Carolina. This new ... For the patients in Rocky Mount and the surrounding ...
(Date:9/2/2014)... CAMBRIDGE, Massachusetts , September 2, 2014 ... experience to BioData,s research and lab management services  ... lab management service, is pleased to announce the appointment ... CEO. Culot most recently served as VP Marketing and ... for life science research and clinical applications. ...
Breaking Biology Technology:Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 3Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 2Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 3Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 4Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 5PMG Research Announces the Formation of its Eleventh Site 2PMG Research Announces the Formation of its Eleventh Site 3Louis Culot Appointed as BioData's CEO 2
... Dr. ... San Antonio and South Central Texas, , ... (PRWEB) June 15, 2010 -- For those looking for a trimmer physique without ... Zeltiq ™ Procedure, a new non-invasive body contouring procedure, at his practice - Advanced ...
... data from a retrospective cohort study showed that up to three quarters ... have a substantial adverse effect on major PD-related clinical and health economic ... Disease and Movement Disorders in Buenos Aires, Argentina ( June ... , "The ...
... leading publication on diversity and business, has recognized University Hospitals as a leader among ... , , ... Companies for Diversity based on results from an extensive questionnaire. This is the first ... , , ...
Cached Biology Technology:Dr. Suresh Koneru Introduces Zeltiq Non-Invasive Procedure For Fat Reduction 2Dr. Suresh Koneru Introduces Zeltiq Non-Invasive Procedure For Fat Reduction 3New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinson's Disease 2New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinson's Disease 3New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinson's Disease 4Diversity Publication Names University Hospitals One of Top Hospital Systems in the Nation 2
(Date:9/2/2014)... perching birds, that migrate by night tend to fly ... reach their destinations. This seasonal difference in flight speed ... migratory flights, says researcher Cecilia Nilsson of Lund University ... Sociobiology . , Nilsson, in a group led ... measure over three years the speed by which birds ...
(Date:9/2/2014)... 2, 2014 Best-selling author Sam Kean stops by ... Megalodon, the 50-foot super shark that, despite what "Shark ... Learn all about it at http://youtu.be/KhFygIoW_MA . , ... of Madness, Love and the History of the World ... the Reactions treatment in a 10-episode video series produced ...
(Date:9/2/2014)... lithographic limestone is well known as a result ... area (for example, Archaeopteryx). Now, for the first ... French equivalent of these outcrops - discoveries which ... water treader. , Despite the abundance of fossils ... been obtained from the Late Kimmeridgian equivalents of ...
Breaking Biology News(10 mins):Migrating birds sprint in spring, but take things easy in autumn 2Exceptionally well preserved insect fossils from the Rhône Valley 2
... Research to be presented at the Annual Meeting of the ... society for research into all aspects of eating and drinking ... their pregnancy were at risk to develop obesity and type ... that both prenatal stress exposure and passive stress coping style ...
... make a person more susceptible to the lung infection ... , the online open-access journal of the American Society ... (METH) significantly enhanced colonization of the lungs by ... and the time to death in mouse models. ...
... mind that is, your happiness affects your genes, ... from UCLA,s Cousins Center for Psychoneuroimmunology and the University of ... What they found is that different types ... People who have high levels of what ...
Cached Biology News:Methamphetamine increases susceptibility to deadly fungal infection 2Methamphetamine increases susceptibility to deadly fungal infection 3Be happy: Your genes may thank you for it 2Be happy: Your genes may thank you for it 3
Goat polyclonal to Factor VIII, prediluted ( Abpromise for all tested applications). Antigen: Full length native protein (purified) (Human): Factor VIII from blood. Entrez GeneID: 2157 Sw...
Anti-Bcl-G (CT) Host: rabbit polyclonal Species Reactivity: human, mouse, rat Applications: WB, IHC Storage: 4C...
Affinity Purified Rabbit Anti-mouse sRANKL Biotinylated Polyclonal Antibody...
Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid Antibodies...
Biology Products: